Home » Topics » BioWorld Science

BioWorld Science
RSS

Skye completes IND-enabling genotoxicity studies for THCVHS

Aug. 11, 2021

Kaleido and COPD Foundation collaborate to advance development of KB-109

Aug. 11, 2021

Anti-PRNP monoclonal antibody decreases tau pathology in mouse Alzheimer's disease model

Aug. 11, 2021

Positive interim data presented from phase I study of FTX-6058

Aug. 11, 2021

aTyr expands its research collaboration with Ohio State University

Aug. 11, 2021

Beta Pharma synthesizes new FGFR inhibitors

Aug. 11, 2021

Mindset presents preclinical data for next-generation psychedelic drug families

Aug. 11, 2021

New MAP4K1 inhibitors identified at Blueprint Medicines

Aug. 11, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents BCR-ABL inhibitors

Aug. 11, 2021

New PSMB8 inhibitors divulged by Shouyao Holdings

Aug. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026